-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on NOV, Lowers Price Target to $15

Benzinga·05/16/2025 16:00:03
Listen to the news
Morgan Stanley analyst Elizabeth Porter maintains NOV (NYSE:NOV) with a Overweight and lowers the price target from $18 to $15.